Publications by authors named "George Maynard"

Claim this Profile
S
Soluble Nogo-Receptor-Fc decoy (AXER-204) in patients with chronic cervical spinal cord injury in the USA: a first-in-human and randomised clinical trial.
George Maynard, Ramakrishnan Kannan, Jian Liu, Weiwei Wang, Tu Kiet T Lam

Lancet Neurol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nogo receptor decoy promotes recovery and corticospinal growth in non-human primate spinal cord injury.
Xingxing Wang, Tianna Zhou, George D Maynard, Pramod S Terse, William B Cafferty

Brain· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Land-use change and the ecological consequences of personality in small mammals.
Allison M Brehm, Alessio Mortelliti, George A Maynard, Joseph Zydlewski

Ecol Lett· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rescue of Transgenic Alzheimer's Pathophysiology by Polymeric Cellular Prion Protein Antagonists.
Erik C Gunther, Levi M Smith, Mikhail A Kostylev, Timothy O Cox, Adam C Kaufman, George D Maynard

Cell Rep· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rescue of Transgenic Alzheimer's Pathophysiology by Polymeric Cellular Prion Protein Antagonists.
Erik C Gunther, Levi M Smith, Mikhail A Kostylev, Timothy O Cox, Adam C Kaufman, George D Maynard

Cell Rep· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravitreal delivery of human NgR-Fc decoy protein regenerates axons after optic nerve crush and protects ganglion cells in glaucoma models.
Xingxing Wang, Jun Lin, Alexander Arzeno, Jin Young Choi, Juliann Boccio, George Maynard

Invest Ophthalmol Vis Sci· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human NgR-Fc decoy protein via lumbar intrathecal bolus administration enhances recovery from rat spinal cord contusion.
Xingxing Wang, Kazim Yigitkanli, Chang-Yeon Kim, Tomoko Sekine-Komo, Dana Wirak, George Maynard

J Neurotrauma· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The newly developed CRF1-receptor antagonists, NGD 98-2 and NGD 9002, suppress acute stress-induced stimulation of colonic motor function and visceral hypersensitivity in rats.
Mulugeta Million, Jing-Fang Zhao, Andrew Luckey, József Czimmer, George D Maynard

PLoS One· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting memory processes with drugs to prevent or cure PTSD.
Christopher K Cain, George D Maynard, John H Kehne

Expert Opin Investig Drugs· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of N-(1-ethylpropyl)-[3-methoxy-5-(2-methoxy-4-trifluoromethoxyphenyl)-6-methyl-pyrazin-2-yl]amine 59 (NGD 98-2): an orally active corticotropin releasing factor-1 (CRF-1) receptor antagonist.
Kevin J Hodgetts, Ping Ge, Taeyoung Yoon, Stéphane De Lombaert, Robbin Brodbeck, George D Maynard

J Med Chem· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emergence of anti-conflict effects of zolpidem in rhesus monkeys following extended post-injection intervals.
James K Rowlett, John H Kehne, Ken J Sprenger, George D Maynard

Psychopharmacology (Berl)· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and characterization of NDT 9513727 [N,N-bis(1,3-benzodioxol-5-ylmethyl)-1-butyl-2,4-diphenyl-1H-imidazole-5-methanamine], a novel, orally bioavailable C5a receptor inverse agonist.
Robbin M Brodbeck, Daniel N Cortright, Andrzej P Kieltyka, Jianying Yu, Carolyn O Baltazar, George D Maynard

J Pharmacol Exp Ther· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Philanthropy is not asking for a favor, it is giving a favor.
George F Maynard

Front Health Serv Manage· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aminopyrazine CB1 receptor inverse agonists.
David J Wustrow, George D Maynard, Jun Yuan, He Zhao, Jianmin Mao

Bioorg Med Chem Lett· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular characterization of the gerbil C5a receptor and identification of a transmembrane domain V amino acid that is crucial for small molecule antagonist interaction.
Stephen M Waters, Robbin M Brodbeck, Jeremy Steflik, Jianying Yu, Carolyn Baltazar, George Maynard

J Biol Chem· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Building relationships a giver at a time.
George F Maynard, Crystal Barnes

AHP J· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis